PFM Health Sciences LP 13D and 13G filings for ESSA Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:06 pm Sale | 2024-12-31 | 13G | ESSA Pharma Inc. EPIX | PFM Health Sciences LP | 0 0.000% | -2,742,936 (Position Closed) | Filing |
| 2024-11-14 4:04 pm Sale | 2024-09-30 | 13G | ESSA Pharma Inc. EPIX | PFM Health Sciences LP | 2,742,936 6.200% | -519,564 (-15.93%) | Filing |
| 2024-02-14 4:06 pm Sale | 2023-12-31 | 13G | ESSA Pharma Inc. EPIX | PFM Health Sciences LP | 3,262,500 7.400% | -581,832 (-15.13%) | Filing |
| 2023-02-14 4:06 pm Unchanged | 2022-12-31 | 13G | ESSA Pharma Inc. EPIX | PFM Health Sciences LP | 3,844,332 8.700% | 0 (Unchanged) | Filing |
| 2022-11-10 4:02 pm Purchase | 2022-10-31 | 13G | ESSA Pharma Inc. EPIX | PFM Health Sciences LP | 3,844,332 8.700% | 3,844,332 (New Position) | Filing |